Psychedelic

It seems that the therapeutic potential of psychedelics is becoming more generally accepted in Virginia, as activists are hoping to expand upon the state’s current psychedelic decriminalization ordinance. State lawmakers Sen. Ghazala Hashmi (D) and Del. Dawn Adams (D) discussed the role...

Psychedelic-focused biotech company Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) recently met with the US Food and Drug Administration (FDA) Center for Devices and Radiological Health (CDRH) with consultation from the Center for Drug Evaluation and Research (CDER) to discuss several...

Psychedelic wellness platform Delic Holding Corp Inc. (CSE: DELC) (OTCQB: DELCF) (FRA:6X0) said Wednesday that Delic Labs has applied for a Health Canada 56 Research Exemption that would allow the scientists to perform research and tests on a host of compounds outside of psychedelic mushrooms,...

This article Jason Najum was originally published on Microdose Psychedelic Insights and appears here with permission. Digital health and therapeutics will play a crucial role in the future of medicine. Across medical and mental health industries, companies are realizing that the confluence of...

Psychedelic wellness platform Delic Holdings Corp (CSE: DELC) (OTCQB: DELCF) (FRA:6X0) announced Thursday a first of its kind partnership with Paradigm Healthcare, an independent clinical laboratory located in St. Simons, Georgia that focuses on high complexity clinical toxicology, in...

Compass Pathways PLC (NASDAQ: CMPS) is often viewed as the leader in the psychedelic sector with smaller companies such as Mind Medicine (OTC: MMEDF) and Mydecine Innovations Group Inc (OTC: MYCOF) often following its moves. After reaching an all-time high of $61.69 on Dec. 14, Compass Pathways...

Entheon Biomedical Corp. (OTC: ENTBF) a company dedicated to the application of the psychedelic DMT in the treatment of addiction, announced the launch of a psychedelics genetic test kit, through its wholly-owned subsidiary, HaluGen Life Sciences Inc. The test will serve as a pre-screening...

A psychedelic medicine biotech company, Mind Medicine Inc. (NEO: MMED) (OTCQB: MMEDF) (DE: MMQ), released full-year 2020 financial results Tuesday.  MindMed posted a net and comprehensive loss of $35.1 million for the year ended Dec. 31, 2020. Its total assets at the end of the reporting...

This article by Jill Ettinger was originally published on Psychedelic Spotlight, and appears here with permission. New York University is expanding its research into psychedelics with the opening of a “one-of-a-kind” psychedelic center, The NYU Langone Center for...

This article by Jill Ettinger was originally published on Psychedelic Spotlight, and appears here with permission. While most of us are eager to put 2020 behind us, a few industries had banner years during lockdown. Pizza delivery and Zoom subscriptions may top the list but it was also a huge...

This article by Jennifer Walker-Journey was originally published on Psychedelic Spotlight, and appears here with permission. Researchers say psychedelics like ayahuasca, psilocybin, ketamine, ibogaine and 5-MeO-DMT prove so beneficial to professional athletes because they have the ability to...

This article by Jennifer Walker-Journey was originally published on Psychedelic Spotlight, and appears here with permission. Online psychedelic support groups have been around for two decades. Here’s how they’re evolving with the times. It was 20 years ago and some of Mike...

This article was originally published on Microdose Psychedelic Insights and appears here with permission. Click here to get your FREE ticket to Psychedelic Capital today! While the tumultuous year that was 2020 brought numerous unforeseen challenges with it, psychedelic medicine made...

This article by Gaurav Dubey was originally published on Microdose Psychedelic Insights and appears here with permission. The revival of psychedelic science and research has produced a fascinating wealth of information about their therapeutic potential. From treatment resistant...

This article was originally published on Cannabis & Tech Today, and appears here with permission. In clinical depression and related disorders, there have not been any significant treatment advancements in over a decade. A handful of biotech and pharmaceutical companies in the...